192 related articles for article (PubMed ID: 15379952)
1. Prostatic ductal adenocarcinoma showing Bcl-2 expression.
Tulunay O; Orhan D; Baltaci S; Gögüş C; Müftüoglu YZ
Int J Urol; 2004 Sep; 11(9):805-8. PubMed ID: 15379952
[TBL] [Abstract][Full Text] [Related]
2. Rare histological patterns of prostatic ductal adenocarcinoma.
Lee TK; Miller JS; Epstein JI
Pathology; 2010 Jun; 42(4):319-24. PubMed ID: 20438402
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical verification of ductal differentiation in prostate cancer.
Tarján M; Lenngren A; Hellberg D; Tot T
APMIS; 2012 Jun; 120(6):510-8. PubMed ID: 22583364
[TBL] [Abstract][Full Text] [Related]
4. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
Tavora F; Epstein JI
Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy.
Abaza R; Diaz LK; Laskin WB; Pins MR
J Urol; 2006 Dec; 176(6 Pt 1):2701-5. PubMed ID: 17085199
[TBL] [Abstract][Full Text] [Related]
6. Emodin induces apoptosis in human prostate cancer cell LNCaP.
Yu CX; Zhang XQ; Kang LD; Zhang PJ; Chen WW; Liu WW; Liu QW; Zhang JY
Asian J Androl; 2008 Jul; 10(4):625-34. PubMed ID: 18478162
[TBL] [Abstract][Full Text] [Related]
7. Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues.
Merseburger AS; Kuczyk MA; Serth J; Bokemeyer C; Young DY; Sun L; Connelly RR; McLeod DG; Mostofi FK; Srivastava SK; Stenzl A; Moul JW; Sesterhenn IA
Oncol Rep; 2003; 10(1):223-8. PubMed ID: 12469173
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen and prostate-specific acid phosphatase in neuroendocrine cells of prostate cancer.
Cohen RJ; Glezerson G; Haffejee Z
Arch Pathol Lab Med; 1992 Jan; 116(1):65-6. PubMed ID: 1370878
[TBL] [Abstract][Full Text] [Related]
9. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.
Yuan TC; Veeramani S; Lin FF; Kondrikou D; Zelivianski S; Igawa T; Karan D; Batra SK; Lin MF
Endocr Relat Cancer; 2006 Mar; 13(1):151-67. PubMed ID: 16601285
[TBL] [Abstract][Full Text] [Related]
10. Pure prostatic papillary adenocarcinoma with ductal features.
Yamashita S; Inaba Y; Soma F; Katayama Y
Hinyokika Kiyo; 2005 Mar; 51(3):207-9; discussion 210. PubMed ID: 15852679
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer.
Tsutsui S; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S
BMC Cancer; 2006 Jul; 6():187. PubMed ID: 16839413
[TBL] [Abstract][Full Text] [Related]
12. Lymphoepithelioma-like carcinoma of the prostate.
Lopez-Beltran A; Cheng L; Prieto R; Blanca A; Montironi R
Hum Pathol; 2009 Jul; 40(7):982-7. PubMed ID: 19269013
[TBL] [Abstract][Full Text] [Related]
13. BCL-2 proto-oncogene expression in prostate cancer and its relationship to the prostatic neuroendocrine cell.
Segal NH; Cohen RJ; Haffejee Z; Savage N
Arch Pathol Lab Med; 1994 Jun; 118(6):616-8. PubMed ID: 8204007
[TBL] [Abstract][Full Text] [Related]
14. Prostatic ductal adenocarcinoma: a mini review.
Epstein JI
Med Princ Pract; 2010; 19(1):82-5. PubMed ID: 19996627
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis in prostate cancer: bax correlation with stage.
Amirghofran Z; Monabati A; Gholijani N
Int J Urol; 2005 Apr; 12(4):340-5. PubMed ID: 15948719
[TBL] [Abstract][Full Text] [Related]
16. [Cystic prostate cancer: a clinical entity of ductal carcinoma].
Zini L; Villers A; Leroy X; Ballereau C; Lemaitre L; Biserte J
Prog Urol; 2004 Jun; 14(3):411-3. PubMed ID: 15373189
[TBL] [Abstract][Full Text] [Related]
17. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
Wang W; Epstein JI
Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772
[TBL] [Abstract][Full Text] [Related]
18. Prostatic neuroendocrine cells have a unique keratin expression pattern and do not express Bcl-2: cell kinetic features of neuroendocrine cells in the human prostate.
Xue Y; Verhofstad A; Lange W; Smedts F; Debruyne F; de la Rosette J; Schalken J
Am J Pathol; 1997 Dec; 151(6):1759-65. PubMed ID: 9403726
[TBL] [Abstract][Full Text] [Related]
19. [Prostatic adenocarcinoma showing features of endometrioid and mucinous carcinomas: a case report].
Nishimura K; Higashino M; Hara T; Oka T
Hinyokika Kiyo; 1995 Oct; 41(10):805-7. PubMed ID: 8533679
[TBL] [Abstract][Full Text] [Related]
20. Leptin and adiponectin interact in the regulation of prostate cancer cell growth via modulation of p53 and bcl-2 expression.
Mistry T; Digby JE; Desai KM; Randeva HS
BJU Int; 2008 May; 101(10):1317-22. PubMed ID: 18279445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
